P-Glycoprotein-Mediated Multidrug Resistance☆

  • Gottesman M
  • 11


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


Resistance to multiple anti-cancer drugs can arise de novo or as a result of chemotherapy of cancer. Expression of the drug efflux pump, P-glycoproten (MDR1), is a contributing cause of failure of chemotherapy. Understanding of the normal function of P-glycoprotein in handling drugs in the body, and its role in conferring anti-cancer drug resistance, has led to new strategies to treat cancer and deliver drugs throughout the body.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in


  • M.M. Gottesman

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free